Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report
- PMID: 6643405
Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report
Abstract
Marked worsening of adverse effects and increased chlorpromazine plasma levels were observed in a 25-year-old schizophrenic outpatient who abruptly stopped smoking cigarettes. Presence and severity of adverse effects and chlorpromazine plasma levels correlated directly with tobacco smoking over a 16-month period.
Similar articles
-
Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.Trop Geogr Med. 1988 Jan;40(1):31-3. Trop Geogr Med. 1988. PMID: 3381314 Clinical Trial.
-
Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.Curr Ther Res Clin Exp. 1973 Feb;15(2):73-7. Curr Ther Res Clin Exp. 1973. PMID: 4632509 Clinical Trial. No abstract available.
-
[Changes in the plasma chlorpromazine level in relation to drug dosage].Psychiatr Pol. 1986 Jul-Aug;20(4):264-7. Psychiatr Pol. 1986. PMID: 3809306 Polish. No abstract available.
-
[Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].Seishin Shinkeigaku Zasshi. 1978 Jul;80(7):405-24. Seishin Shinkeigaku Zasshi. 1978. PMID: 724820 Japanese. No abstract available.
-
The assay of chlorpromazine and metabolites in blood, urine, and other tissues.CRC Crit Rev Clin Lab Sci. 1971 Sep;2(3):347-91. doi: 10.3109/10408367109151312. CRC Crit Rev Clin Lab Sci. 1971. PMID: 4942646 Review. No abstract available.
Cited by
-
Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs.Cell Mol Neurobiol. 1999 Aug;19(4):491-510. doi: 10.1023/a:1006938908284. Cell Mol Neurobiol. 1999. PMID: 10379422 Free PMC article. Review.
-
A clinical approach to help psychiatric patients with smoking cessation.Psychiatr Q. 1992 Spring;63(1):27-39. doi: 10.1007/BF01064680. Psychiatr Q. 1992. PMID: 1438602 Review.
-
Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.Clin Pharmacokinet. 1989 Aug;17(2):90-108. doi: 10.2165/00003088-198917020-00003. Clin Pharmacokinet. 1989. PMID: 2673608 Review.
-
Drug interactions with tobacco smoking. An update.Clin Pharmacokinet. 1999 Jun;36(6):425-38. doi: 10.2165/00003088-199936060-00004. Clin Pharmacokinet. 1999. PMID: 10427467 Review.
-
Long-term depot antipsychotics. A risk-benefit assessment.Drug Saf. 1994 Jun;10(6):464-79. doi: 10.2165/00002018-199410060-00005. Drug Saf. 1994. PMID: 7917075 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical